| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |